Category: Pharma News
Phase-II of the ATH434 trial for multiple system atrophy patient dosing has started, according to Alterity Therapeutics.
The first participant in Alterity Therapeutics’ phase 2 clinical trial of ATH434 in multiple system atrophy (MSA), a…
H3N2 Influenza: Sings and Symptoms, Treatments and Precautions
What is H3N2 Influenza? A subtype of influenza called H3N2 In India, a virus has been rapidly spreading, resulting…
All medical colleges are required by NMC to enrol with IPC as AMCs in order to report ADRs.
As part of the Pharmacovigilance Plan of India, the National Medical Commission (NMC) has ordered all accredited medical…
Helping the vulnerable Indian community survive sudden cardiac arrests is MedLern HeartCode
A vulnerable population in India is now being helped to survive abrupt cardiac arrests thanks to MedLern HeartCode…
In a phase 2a research using Lenvima and fostrox to treat hepatocellular cancer, Medivir has started treating patients.
The first patient with hepatocellular carcinoma (HCC) has begun treatment in phase 2a with the candidate drug fostroxacitabine…
Amneal Announces U.S. FDA Filing Acceptance of Abbreviated New Drug Application for Naloxone Hydrochloride Nasal Spray, USP, 4mg
BRIDGEWATER, N.J.–(BUSINESS WIRE)– Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced the U.S. Food and Drug Administration (FDA) has accepted…
Occlutech starts patient dosing in the FROST study to look into using an atrial flow regulator to treat heart failure with preserved ejection fraction (HFpEF).
One of the top manufacturers of minimally invasive structural heart disease devices, Occlutech Holding AG (Occlutech), has announced…
Zydus receives final approval from the USFDA for Lenalidomide Capsules, 2.5 mg and 20 mg
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United…
To export levothyroxine and levonorgestrel to Guatemala, Pharmexcil urged its members to submit EOIs.
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged its member companies to submit their expressions of…
Two more medical device testing facilities are approved by CDSCO.
According to the 2017 Medical Devices Regulations (MDR), the Central Drugs Standard Control Organization (CDSCO) has authorised two…
